Webinar offers insights into FP Market Report

18th January 2024

Last month, we announced the launch of the 2023 Family Planning Market Report by the Clinton Health Access Initiative (CHAI) and the RHSC. The report found that over 2018-22, the public-sector contraceptive market grew from US$247...

Mifepristone included in Ecuador’s Essential Medicines List

10th January 2024

Ecuador’s Ministry of Health has successfully included mifepristone in its National Essential Medicines List. The long process leading up to this moment was supported by RHSC/ForoLAC and partners from CLACAI and IPAS, who provided...

Category: ForoLAC

Ambitious targets drive Ouagadougou Partnership meeting

5th January 2024

In December, RHSC representatives joined West African stakeholders in Abidjan at the Ouagadougou Partnership (OP) annual members meeting bringing together countries committed to reaching 13 million modern contraceptive method...

Category: Global FP VAN

Leadership updates

1st January 2024

Both the Menstrual Health Supplies Workstream and the Safe Abortion Supplies Workstream welcomed news that their leaders were staying on for a second two-year term. We thank both Tanya Mahajan (The Pad Project) and Petra Procter...

Category: New/Underused RH Technologies Caucus

GMM feedback promises overwhelming repeat attendance

12th December 2023

99% of respondents to the General Membership Meeting exit survey plan to return for the next conference. Plenary panels on the future of financing for RH supplies, regional manufacturing, and gender equity and social inclusion...